Inside Drug Pricing

Fowler: ‘Stay Tuned’ For Drug Pricing Demos To Be Made Public

By Gabrielle Wanneh / February 1, 2023 at 11:58 AM

A White House-mandated report listing potential demonstrations the federal government can use to lower prescription drug prices will be made public soon, CMS innovation center chief Elizabeth Fowler said during a fireside chat at the Council for Affordable Health Coverage’s Price of Good Health Summit Tuesday (Jan. 31).

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

Fowler: ‘Stay Tuned’ For Drug Pricing Demos To Be Made Public

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.